The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

CRISPR Therapeutics AG (CRSP) closed at $41.21 in the latest trading session, marking a -1.44% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.47%. Meanwhile ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

Once a week, Sun Kai has a video call with his mother, and they discuss his day-to-day life. But Sun’s mother died five years ...

Results prove that inversions can be generated in plants without causing further unwanted changes in the expression of genetic information.

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

Research in genetics and biotechnology has advanced by leaps and bounds in recent years, offering new hope for the treatment ...

Morgan Stanley lowered the firm’s price target on Crispr Therapeutics (CRSP) to $30 from $45 and keeps an Underweight rating on the shares. The ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Robert F. Kennedy Jr. will be pulling his investments from two biotechs if he is confirmed to lead the U.S. Department of ...

Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for CRISPR Therapeutics in a note issued to investors ...